We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells

News   Mar 28, 2013

 
Medicyte GmbH Signs Agreement with Life Technologies to Develop Next Generation Upcyte® Cells
 
 
 

RELATED ARTICLES

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

The Fluid That Feeds Tumor Cells

News

The substance that bathes tumors in the body is quite different from the medium used to grow cancer cells in the lab, biologists report.

READ MORE

Synthetic Peptide Inhibits Toxicity and Aggregation of Protein in Alzheimer's Disease

News

Alzheimer’s is a disease of aggregation. Neurons in the human brain make a protein called amyloid beta. Now, a team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit those small, toxic aggregates.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE